BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Felmingham D, Feldman C, Hryniewicz W, Klugman K, Kohno S, Low DE, Mendes C, Rodloff AC. Surveillance of resistance in bacteria causing community-acquired respiratory tract infections. Clin Microbiol Infect 2002;8 Suppl 2:12-42. [PMID: 12427206 DOI: 10.1046/j.1469-0691.8.s.2.5.x] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Marchese A, Schito GC. Recent findings from multinational resistance surveys: are we ‘PROTEKTed’ from resistance? International Journal of Antimicrobial Agents 2007;29:S2-5. [DOI: 10.1016/s0924-8579(07)70003-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
2 Anderson VR, Perry CM. Levofloxacin : a review of its use as a high-dose, short-course treatment for bacterial infection. Drugs 2008;68:535-65. [PMID: 18318569 DOI: 10.2165/00003495-200868040-00011] [Cited by in Crossref: 76] [Cited by in F6Publishing: 59] [Article Influence: 5.4] [Reference Citation Analysis]
3 Pelton SI, Hammerschlag MR. Overcoming current obstacles in the management of bacterial community-acquired pneumonia in ambulatory children. Clin Pediatr (Phila) 2005;44:1-17. [PMID: 15678226 DOI: 10.1177/000992280504400101] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
4 Mushtaq S, Warner M, Ge Y, Kaniga K, Livermore DM. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes. Journal of Antimicrobial Chemotherapy 2007;60:300-11. [DOI: 10.1093/jac/dkm150] [Cited by in Crossref: 106] [Cited by in F6Publishing: 104] [Article Influence: 7.1] [Reference Citation Analysis]
5 Shariatzadeh MR, Huang JQ, Tyrrell GJ, Johnson MM, Marrie TJ. Bacteremic Pneumococcal Pneumonia: A Prospective Study in Edmonton and Neighboring Municipalities. Medicine 2005;84:147-61. [DOI: 10.1097/01.md.0000164302.03972.d7] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 2.0] [Reference Citation Analysis]
6 Marple BF, Brunton S, Ferguson BJ. Acute bacterial rhinosinusitis: a review of U.S. treatment guidelines. Otolaryngol Head Neck Surg 2006;135:341-8. [PMID: 16949962 DOI: 10.1016/j.otohns.2005.12.021] [Cited by in Crossref: 27] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
7 Liebowitz LD, Slabbert M, Huisamen A. National surveillance programme on susceptibility patterns of respiratory pathogens in South Africa: moxifloxacin compared with eight other antimicrobial agents. J Clin Pathol 2003;56:344-7. [PMID: 12719453 DOI: 10.1136/jcp.56.5.344] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 1.4] [Reference Citation Analysis]
8 Dias R, Caniça M. Trends in resistance to penicillin and erythromycin of invasive pneumococci in Portugal. Epidemiol Infect 2008;136:928-39. [PMID: 17697443 DOI: 10.1017/S0950268807009405] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
9 Cantón R, Mazzariol A, Morosini M, Baquero F, Cornaglia G. Telithromycin activity is reduced by efflux in Streptococcus pyogenes. Journal of Antimicrobial Chemotherapy 2005;55:489-95. [DOI: 10.1093/jac/dki033] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
10 Machado JN, Costa JC, Costa T, Rodrigues C. Mucosal bacterial vaccines in clinical practice - a novel approach to an old problem? Rev Assoc Med Bras (1992) 2020;66:659-65. [PMID: 32638954 DOI: 10.1590/1806-9282.66.5.659] [Reference Citation Analysis]
11 Moon SK, Lim DJ. Intratympanic Gene Delivery of Antimicrobial Molecules in Otitis Media. Curr Allergy Asthma Rep 2015;15:14. [PMID: 26130474 DOI: 10.1007/s11882-015-0517-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
12 Salerno SN, Edginton A, Cohen-Wolkowiez M, Hornik CP, Watt KM, Jamieson BD, Gonzalez D. Development of an Adult Physiologically Based Pharmacokinetic Model of Solithromycin in Plasma and Epithelial Lining Fluid. CPT Pharmacometrics Syst Pharmacol 2017;6:814-22. [PMID: 29068158 DOI: 10.1002/psp4.12252] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
13 Nunes S, Sá-Leão R, Carriço J, Alves CR, Mato R, Avô AB, Saldanha J, Almeida JS, Sanches IS, de Lencastre H. Trends in drug resistance, serotypes, and molecular types of Streptococcus pneumoniae colonizing preschool-age children attending day care centers in Lisbon, Portugal: a summary of 4 years of annual surveillance. J Clin Microbiol 2005;43:1285-93. [PMID: 15750097 DOI: 10.1128/JCM.43.3.1285-1293.2005] [Cited by in Crossref: 40] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
14 Cantón R. Role of the microbiology laboratory in infectious disease surveillance, alert and response. Clin Microbiol Infect 2005;11 Suppl 1:3-8. [PMID: 15816099 DOI: 10.1111/j.1469-0691.2005.01081.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
15 Vicente M, Hodgson J, Massidda O, Tonjum T, Henriques-normark B, Ron EZ. The fallacies of hope: will we discover new antibiotics to combat pathogenic bacteria in time? FEMS Microbiol Rev 2006;30:841-52. [DOI: 10.1111/j.1574-6976.2006.00038.x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 2.9] [Reference Citation Analysis]
16 Noreddin AM, Elkhatib WF. Levofloxacin in the treatment of community-acquired pneumonia. Expert Rev Anti Infect Ther 2010;8:505-14. [PMID: 20455679 DOI: 10.1586/eri.10.35] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
17 Şener B, Tunçkanat F, Ulusoy S, Tünger A, Söyletir G, Mülazimoğlu L, Gürler N, Öksüz L, Köksal İ, Aydın K, Yalçın AN, Öğünç D, Acar A, Sievers J. A survey of antibiotic resistance in Streptococcus pneumoniae and Haemophilus influenzae in Turkey, 2004–2005. Journal of Antimicrobial Chemotherapy 2007;60:587-93. [DOI: 10.1093/jac/dkm232] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
18 Chatterjee D, Sen S, Begum SA, Adhikari A, Hazra A, Das AK. A questionnaire-based survey to ascertain the views of clinicians regarding rational use of antibiotics in teaching hospitals of Kolkata. Indian J Pharmacol 2015;47:105-8. [PMID: 25821321 DOI: 10.4103/0253-7613.150373] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
19 Cohen R. Defining the optimum treatment regimen for azithromycin in acute tonsillopharyngitis. Pediatr Infect Dis J 2004;23:S129-34. [PMID: 14770076 DOI: 10.1097/01.inf.0000112527.33870.0d] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
20 Chiang WC, Teoh OH, Chong CY, Goh A, Tang JP, Chay OM. Epidemiology, clinical characteristics and antimicrobial resistance patterns of community-acquired pneumonia in 1702 hospitalized children in Singapore. Respirology 2007;12:254-61. [PMID: 17298459 DOI: 10.1111/j.1440-1843.2006.01036.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 2.3] [Reference Citation Analysis]
21 Capitano B, Mattoes HM, Shore E, O'Brien A, Braman S, Sutherland C, Nicolau DP. Steady-state intrapulmonary concentrations of moxifloxacin, levofloxacin, and azithromycin in older adults. Chest 2004;125:965-73. [PMID: 15006955 DOI: 10.1378/chest.125.3.965] [Cited by in Crossref: 84] [Cited by in F6Publishing: 82] [Article Influence: 4.7] [Reference Citation Analysis]
22 Finch R. Controlling antibiotic resistance by rapid identification of susceptible target infections and pathogen recognition: a preface to the Proceedings of the IFAR* Colloquium 2005. Clinical Microbiology and Infection 2006;12:1-2. [DOI: 10.1111/j.1469-0691.2006.01650.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
23 Vanhoof R, Brouillard J, Damée S, d’Hondt N, Haccourt A, Mansoor I, Marchal J, Philippart I, Trigaux F, Van Bosterhaut B, Rossi C, Van Bossuyt E. HIGH PREVALENCE OF PENICILLIN RESISTANCE AND COMPARATIVE IN VITRO ACTIVITY OF VARIOUS ANTIBIOTICS IN CLINICAL ISOLATES OF STREPTOCOCCUS PNEUMONIAE ISOLATED IN THE PROVINCE OF HAINAUT DURING WINTER 2004. Acta Clinica Belgica 2014;60:345-9. [DOI: 10.1179/acb.2005.052] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
24 Cizman M, Beovic B, Krcmery V, Barsic B, Tamm E, Ludwig E, Pelemis M, Karovski K, Grzesiowski P, Gardovska D, Volokha A, Keuleyan E, Stratchounski L, Dumitru C, Titov LP, Usonis V, Dvorák P. Antibiotic policies in Central Eastern Europe. International Journal of Antimicrobial Agents 2004;24:199-204. [DOI: 10.1016/j.ijantimicag.2004.03.016] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 1.0] [Reference Citation Analysis]
25 Dias R, Louro D, Caniça M. Antimicrobial susceptibility of invasive Streptococcus pneumoniae isolates in Portugal over an 11-year period. Antimicrob Agents Chemother 2006;50:2098-105. [PMID: 16723571 DOI: 10.1128/AAC.00198-06] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
26 van Rensburg D, Fogarty C, De Salvo MC, Rangaraju M, Nusrat R. Efficacy of oral telithromycin in community-acquired pneumonia caused by resistant Streptococcus pneumoniae. Journal of Infection 2005;51:201-5. [DOI: 10.1016/j.jinf.2004.11.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
27 Metlay JP, Singer DE. Outcomes in lower respiratory tract infections and the impact of antimicrobial drug resistance. Clinical Microbiology and Infection 2002;8:1-11. [DOI: 10.1046/j.1469-0691.8.s.2.4.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 1.9] [Reference Citation Analysis]
28 Noreddin AM, Elkhatib WF, Cunnion KM, Zhanel GG. Cumulative clinical experience from over a decade of use of levofloxacin in community-acquired pneumonia: critical appraisal and role in therapy. Drug Healthc Patient Saf 2011;3:59-68. [PMID: 22046107 DOI: 10.2147/DHPS.S15599] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
29 Klossek JM, Federspil P. Update on treatment guidelines for acute bacterial sinusitis: Treatment Guidelines for Acute Bacterial Sinusitis. International Journal of Clinical Practice 2005;59:230-8. [DOI: 10.1111/j.1742-1241.2005.00378.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
30 Low DE, Pichichero ME, Schaad UB. Optimizing antibacterial therapy for community-acquired respiratory tract infections in children in an era of bacterial resistance. Clin Pediatr (Phila) 2004;43:135-51. [PMID: 15024437 DOI: 10.1177/000992280404300203] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
31 Zhang YY, Huang HH, Ren ZY, Zheng HG, Yu YS, Lü XJ, Xiao ZK, Yang HF, Xiu QY, Chen BY, Yue HM, Hao QL, Huang JA, Ma H, Xiao W, Guo DY, Si B, Sun SH, Zhang W, Li QH, Shen HH, Duan J, Li HY, Yao WZ, Gu JM, Xia QM, Ying KJ, Liu A, Yang HP, Shi MH, Sun TY, Ding GH, Wu GM. Clinical evaluation of oral levofloxacin 500 mg once-daily dosage for treatment of lower respiratory tract infections and urinary tract infections: a prospective multicenter study in China. J Infect Chemother 2009;15:301-11. [PMID: 19856068 DOI: 10.1007/s10156-009-0713-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
32 Christiansen K, Carbon C, Cars O. Moving from recommendation to implementation and audit: Part 2. Review of interventions and audit. Clinical Microbiology and Infection 2002;8:107-28. [DOI: 10.1046/j.1469-0691.8.s.2.9.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
33 Phuong NTK, Hoang TT, Van PH, Tu L, Graham SM, Marais BJ. Encouraging rational antibiotic use in childhood pneumonia: a focus on Vietnam and the Western Pacific Region. Pneumonia (Nathan) 2017;9:7. [PMID: 28702309 DOI: 10.1186/s41479-017-0031-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
34 Larson E, Lin SX, Gomez-Duarte C. Antibiotic use in Hispanic households, New York city. Emerg Infect Dis 2003;9:1096-102. [PMID: 14519246 DOI: 10.3201/eid0909.020371] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 1.6] [Reference Citation Analysis]
35 Ulloa-gutierrez R, Avila-aguero ML, Herrera ML, Herrera JF, Arguedas A. Invasive pneumococcal disease in Costa Rican children: a seven year survey: . The Pediatric Infectious Disease Journal 2003;22:1069-74. [DOI: 10.1097/01.inf.0000101475.45195.b1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
36 Alecsandru D, Valor L, Sánchez-Ramón S, Gil J, Carbone J, Navarro J, Rodríguez J, Rodríguez-Sainz C, Fernández-Cruz E. Sublingual therapeutic immunization with a polyvalent bacterial preparation in patients with recurrent respiratory infections: immunomodulatory effect on antigen-specific memory CD4+ T cells and impact on clinical outcome. Clin Exp Immunol 2011;164:100–7. [PMID: 21391984 DOI: 10.1111/j.1365-2249.2011.04320.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 28] [Article Influence: 3.3] [Reference Citation Analysis]
37 Finch RG, Metlay JP, Davey PG, Baker LJ. Educational interventions to improve antibiotic use in the community: report from the International Forum on Antibiotic Resistance (IFAR) colloquium, 2002. The Lancet Infectious Diseases 2004;4:44-53. [DOI: 10.1016/s1473-3099(03)00860-0] [Cited by in Crossref: 102] [Cited by in F6Publishing: 45] [Article Influence: 5.7] [Reference Citation Analysis]
38 Carbon C, Cars O, Christiansen K. Moving from recommendation to implementation and audit: Part 1. Current recommendations and programs: a critical commentary. Clinical Microbiology and Infection 2002;8:92-106. [DOI: 10.1046/j.1469-0691.8.s.2.8.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
39 . Diretrizes Brasileiras de Rinossinusites. Rev Bras Otorrinolaringol 2008;74:6-59. [DOI: 10.1590/s0034-72992008000700002] [Cited by in Crossref: 4] [Article Influence: 0.3] [Reference Citation Analysis]
40 Ziebuhr W, Xiao K, Coulibaly B, Schwarz R, Dandekar T. Pharmacogenomic strategies against resistance development in microbial infections. Pharmacogenomics 2004;5:361-79. [DOI: 10.1517/14622416.5.4.361] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
41 Fogarty CM, Buchanan P, Aubier M, Baz M, van Rensburg D, Rangaraju M, Nusrat R. Telithromycin in the treatment of pneumococcal community-acquired respiratory tract infections: a review. International Journal of Infectious Diseases 2006;10:136-47. [DOI: 10.1016/j.ijid.2005.01.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
42 Morel CM, de Kraker MEA, Harbarth S; Enhanced Surveillance Expert Consensus Group (CANSORT-SCI). Surveillance of Resistance to New Antibiotics in an Era of Limited Treatment Options. Front Med (Lausanne) 2021;8:652638. [PMID: 33954161 DOI: 10.3389/fmed.2021.652638] [Reference Citation Analysis]
43 Benouda A, Ben Redjeb S, Hammami A, Sibille S, Tazir M, Ramdani-bouguessa N. Antimicrobial Resistance of Respiratory Pathogens in North African Countries. Journal of Chemotherapy 2013;21:627-32. [DOI: 10.1179/joc.2009.21.6.627] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
44 Zafar A, Hasan R, Nizamuddin S, Mahmood N, Mukhtar S, Ali F, Morrissey I, Barker K, Torumkuney D. Antibiotic susceptibility in Streptococcus pneumoniae, Haemophilus influenzae and Streptococcus pyogenes in Pakistan: a review of results from the Survey of Antibiotic Resistance (SOAR) 2002-15. J Antimicrob Chemother 2016;71 Suppl 1:i103-9. [PMID: 27048578 DOI: 10.1093/jac/dkw076] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
45 Marrie T. Therapeutic implications of macrolide resistance in pneumococcal community-acquired lower respiratory tract infections: Therapeutic Implications Of Macrolide Resistance. International Journal of Clinical Practice 2004;58:769-76. [DOI: 10.1111/j.1368-5031.2004.00152.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]